Overview

Chemotherapy Treatment in Re-occurring Non Small Cell Lung Cancer (NSCLC) After Previous Chemotherapy and Surgical Removal of the NSCLC Tumor

Status:
Terminated

Trial end date:
2009-04-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to help answer: - Whether pemetrexed, gemcitabine and/or carboplatin can shrink tumor(s) or make tumor(s) disappear in patients with relapsed lung cancer (lung cancer that has come back after surgical removal and chemotherapy), and to determine how long this will last - Whether pemetrexed, gemcitabine and/or carboplatin can help patients with relapsed lung cancer live longer

Phase:

Phase 2

Details

Lead Sponsor:

Eli Lilly and Company

Treatments:

Carboplatin
Gemcitabine
Pemetrexed